Regenerative medicine: targeted genome editing in vivo

The CRISPR/Cas system has proven to be a powerful gene editing tool both in vitro and in vivo. A recent flurry of studies of in vivo gene editing using the CRISPR/Cas system bring bright prospects in creating animal models and targeted gene therapy of human genetic diseases.

Gardado en:
Detalles Bibliográficos
Publicado en:Cell Res
Main Authors: Wang, Lixia, Wu, Jun, Fang, Weiwei, Liu, Guang-Hui, Belmonte, Juan Carlos Izpisua
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2015
Assuntos:
Research Highlight
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349243/
https://ncbi.nlm.nih.gov/pubmed/25633595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2015.11
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares